Hanover (THG) Insider Filing: 30.586 RSUs Granted to Executive VP
Rhea-AI Filing Summary
Richard W. Lavey, Executive Vice President and director of Hanover Insurance Group (THG), reported a non-derivative acquisition on 09/26/2025. The Form 4 shows 30.586 shares acquired at a price of $0 and reports 39,142.294 shares beneficially owned following the transaction. The filing explains these shares are restricted stock units (RSUs) issued under the company's 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs; these RSUs vest on the third anniversary of the original RSU grant date. The filing is signed via confirming statement by Lindsay L. Katz on 09/30/2025.
Positive
- Grant disclosed under 2022 LTIP with clear vesting terms (third anniversary) indicating structured long‑term alignment
- Zero purchase price indicates these are dividend equivalent RSUs, a standard and predictable compensation mechanism
- Complete reporting details including post‑transaction beneficial ownership (39,142.294 shares) and signatory confirming statement
Negative
- None.
Insights
TL;DR: Small, zero-cost RSU grant recorded as dividend equivalents; shows ongoing executive equity compensation but not a material ownership change.
The Form 4 documents a grant of 30.586 non‑derivative shares (reported as RSUs) at $0 and total beneficial ownership of 39,142.294 shares after the grant. The filing explicitly states these RSUs arise from dividend equivalent accruals under the 2022 LTIP and will vest on the third anniversary of the underlying awards. This is a routine executive equity compensation disclosure rather than a purchase or sale, and it reflects standard long‑term incentive mechanics rather than a market transaction.
TL;DR: Transaction is a compensatory grant of dividend-equivalent RSUs; governance disclosure requirements appear satisfied.
The report identifies the reporting person as an officer and director and discloses the nature of the grant as dividend equivalent RSUs under the 2022 Long‑Term Incentive Plan. It specifies the vesting condition (third anniversary of the original grant) and provides post‑transaction beneficial ownership. The form is signed via a confirming statement, meeting procedural signature disclosure. No additional governance events or deviations are stated in the filing.